TNThomas Nebl

Thomas Nebl

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Thomas Nebl has a total of 294 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    High ploidy large cytoplasmic megakaryocytes are hematopoietic stem cells regulators and essential for platelet production

    by Shen Y. Heazlewood, Tanveer Ahmad, Benjamin Cao, Huimin Cao, Melanie Domingues, Xuan Sun, Chad K. Heazlewood, Songhui Li, Brenda Williams, Madeline Fulton, et al.

    Megakaryocytes (MK) generate platelets. Recently, we and others, have reported MK also regulate hematopoietic stem cells (HSC). Here we show high ploidy large cytoplasmic megakaryocytes (LCM) are critical negative regulators of HSC and critical for platelet formation. Using a mouse knockout model (Pf4-Srsf3Δ/Δ) with normal MK numbers, but essentially devoid of LCM, we demonstrate a pronounced increase in BM HSC concurrent with endogenous mobilization and extramedullary hematopoiesis. Severe thrombocytopenia is observed in animals with diminished LCM, although there is no change in MK ploidy distribution, uncoupling endoreduplication and platelet production. When HSC isolated from a microenvironment essentially devoid of LCM reconstitute hematopoiesis in lethally irradiated mice, the absence of LCM increases HSC in BM, blood and spleen, and the recapitulation of thrombocytopenia. In contrast, following a competitive transplant using minimal numbers of WT HSC together with HSC from a microenvironment with diminished LCM, sufficient WT HSC-generated LCM regulates a normal HSC pool and prevents thrombocytopenia. Importantly, LCM are conserved in humans.


  • Open Access

    Plasmodium falciparum exoerythrocytic forms require the PTEX translocon for development in human hepatocytes

    by Robyn McConville, Jelte Krol, Ryan Steel, Matthew O'NEill, Bethany Davey, Anthony Hodder, Tom Nebl, Alan Cowman, N. M. Kneteman, Justin Boddey

    Plasmodium falciparum assembles a protein translocon (PTEX) at the parasitophorous vacuole membrane (PVM) of infected erythrocytes, through which several hundred proteins are exported. The preceding Plasmodium liver stage develops in hepatocytes within a PVM; however, the importance of PTEX and identification of exported proteins in P. falciparum liver stages remains unexplored. Here, we apply the FlpL/ FRT system to P. falciparum NF54 to conditionally excise genes in sporozoites, enabling studies at the liver stage. Conditional disruption of PTEX components PTEX150 and EXP2 in sporozoites does not affect their development or infectivity but attenuates liver stage growth. While PTEX150-deficiency significantly reduces liver load in humanized mice, EXP2-deficiency conferred a severe fitness cost, demonstrating that PTEX is essential for P. falciparum liver stage development. We show that liver specific protein 2 (LISP2) and circumsporozoite protein (CSP) contain putative PEXEL sequences cleaved by plasmepsin V, yet they localize to the PVM of infected hepatocytes. The abundance of LISP2 is reduced in PTEX-deficient liver stages, suggesting this protein is degraded in the absence of a functioning PTEX complex. This study employs the FlpL/ FRT system for functional analysis of P. falciparum pre-erythrocytic biology, revealing that the protein export translocon required for growth in erythrocytes is essential for P. falciparum development in hepatocytes and normal LISP2 expression. It also describes two P. falciparum proteins that contain putative PEXEL motifs that are targeted to the PVM.


  • Open Access

    The role of glycosylation in amyloid fibril formation of bovine κ-casein

    by Barana Hewa Nadugala, Rick Hantink, Tom Nebl, Jacinta White, Charles N. Pagel, C.S. Ranadheera, Amy Logan, Jared K. Raynes


  • Open Access

    Design of a methotrexate-controlled chemical dimerization system and its use in bio-electronic devices

    by Zhong Guo, Oleh Smutok, Wayne A. Johnston, Patricia Walden, Jacobus P. J. Ungerer, Thomas S. Peat, Janet Newman, Jake Parker, Tom Nebl, Caryn Hepburn, et al.

    Natural evolution produced polypeptides that selectively recognize chemical entities and their polymers, ranging from ions to proteins and nucleic acids. Such selective interactions serve as entry points to biological signaling and metabolic pathways. The ability to engineer artificial versions of such entry points is a key goal of synthetic biology, bioengineering and bioelectronics. We set out to map the optimal strategy for developing artificial small molecule:protein complexes that function as chemically induced dimerization (CID) systems. Using several starting points, we evolved CID systems controlled by a therapeutic drug methotrexate. Biophysical and structural analysis of methotrexate-controlled CID system reveals the critical role played by drug-induced conformational change in ligand-controlled protein complex assembly. We demonstrate utility of the developed CID by constructing electrochemical biosensors of methotrexate that enable quantification of methotrexate in human serum. Furthermore, using the methotrexate and functionally related biosensor of rapamycin we developed a multiplexed bioelectronic system that can perform repeated measurements of multiple analytes. The presented results open the door for construction of genetically encoded signaling systems for use in bioelectronics and diagnostics, as well as metabolic and signaling network engineering.


  • Open Access

    Purification of an insect juvenile hormone receptor complex enables insights into its post-translational phosphorylation

    by Marek Jindra, William J. McKinstry, Thomas Nebl, Lenka Bittova, Bin Ren, Jan Shaw, Tram Phan, Louis Lu, Jason K.K. Low, Joel P. Mackay, et al.


  • Open Access

    The Glitazone Class of Drugs as Carbonic Anhydrase Inhibitors—A Spin-Off Discovery from Fragment Screening

    by Sarah L. Mueller, Panagiotis K. Chrysanthopoulos, Maria A. Halili, Caryn Hepburn, Tom Nebl, Claudiu T. Supuran, Alessio Nocentini, Thomas S. Peat, Sally-Ann Poulsen

    The approved drugs that target carbonic anhydrases (CA, EC 4.2.1.1), a family of zinc metalloenzymes, comprise almost exclusively of primary sulfonamides (R-SO2NH2) as the zinc binding chemotype. New clinical applications for CA inhibitors, particularly for hard-to-treat cancers, has driven a growing interest in the development of novel CA inhibitors. We recently discovered that the thiazolidinedione heterocycle, where the ring nitrogen carries no substituent, is a new zinc binding group and an alternate CA inhibitor chemotype. This heterocycle is curiously also a substructure of the glitazone class of drugs used in the treatment options for type 2 diabetes. Herein, we investigate and characterise three glitazone drugs (troglitazone 11, rosiglitazone 12 and pioglitazone 13) for binding to CA using native mass spectrometry, protein X-ray crystallography and hydrogen–deuterium exchange (HDX) mass spectrometry, followed by CA enzyme inhibition studies. The glitazone drugs all displayed appreciable binding to and inhibition of CA isozymes. Given that thiazolidinediones are not credited as a zinc binding group nor known as CA inhibitors, our findings indicate that CA may be an off-target of these compounds when used clinically. Furthermore, thiazolidinediones may represent a new opportunity for the development of novel CA inhibitors as future drugs.


  • Dual Site-Specific Labeling of an Antibody Fragment through Sortase A and π-Clamp Conjugation

    by Michael David Lee, Wing Yin Tong, Thomas Nebl, Lesley A. Pearce, Tam M. Pham, Arghavan Golbaz-Hagh, Simon Puttick, Stephen Rose, Timothy E. Adams, Charlotte C. Williams

    The functionalization of proteins with different cargo molecules is highly desirable for a broad range of applications. However, the reproducible production of defined conjugates with multiple functionalities is a significant challenge. Herein we report the dual site-specific labelling of an antibody fragment, utilizing the orthogonal Sortase A and π-clamp conjugation methods, and demonstrate that binding of the antibody fragment to its target receptor is retained after dual labelling.


  • Open Access

    Engineered Enzymes that Retain and Regenerate their Cofactors Enable Continuous-Flow Biocatalysis

    by Carol J. Hartley, Charlotte C. Williams, Judith A. Scoble, Quentin I. Churches, Andrea North, Nigel G. French, Tom Nebl, Greg Coia, Andrew C. Warden, Greg Simpson, et al.

    Biocatalysis is used for many chemical syntheses due to its high catalytic rates, specificities and operation under ambient conditions. Continuous-flow chemistry offers advantages to biocatalysis, avoiding process issues caused by substrate/product inhibition, equilibrium controlled limitations on yield and allosteric control. Modular continuous-flow biochemistry would also allow the flexible assembly of different complex multistep reactions. Here we tackle some technical challenges that currently prohibit the wide-spread use of continuous flow biocatalysis; cofactor immobilization and site-specific immobilization. We provide the first example of enzymes engineered to retain and recycle their cofactors, and the use of these enzymes in continuous production of chiral pharmaceutical intermediates.


  • Incorporation of hydroxyproline in bacterial collagen from Streptococcus pyogenes

    by Yong Y. Peng, Thomas Nebl, Veronica Glattauer, John A.M. Ramshaw


  • Plasmepsin V cleaves malaria effector proteins in a distinct endoplasmic reticulum translocation interactome for export to the erythrocyte

    by Danushka S. Marapana, Laura F. Dagley, Jarrod J. Sandow, Thomas Nebl, Tony Triglia, Michał Pasternak, Benjamin K. Dickerman, Brendan S. Crabb, Paul R. Gilson, Andrew I. Webb, et al.

    Plasmodium falciparum exports hundreds of virulence proteins within infected erythrocytes, a process that requires cleavage of a pentameric motif called Plasmodium export element or vacuolar transport signal by the endoplasmic reticulum (ER)-resident protease plasmepsin V. We identified plasmepsin V-binding proteins that form a unique interactome required for the translocation of effector cargo into the parasite ER. These interactions are functionally distinct from the Sec61–signal peptidase complex required for the translocation of proteins destined for the classical secretory pathway. This interactome does not involve the signal peptidase (SPC21) and consists of PfSec61, PfSPC25, plasmepsin V and PfSec62, which is an essential component of the post-translational ER translocon. Together, they form a distinct portal for the recognition and translocation of a large subset of Plasmodium export element effector proteins into the ER, thereby remodelling the infected erythrocyte that is required for parasite survival and pathogenesis.